Publicly accessible evidence of health-related quality of life benefits associated with cancer drugs approved by the European Medicines Agency between 2009 and 2015
Keyword(s):
2020 ◽
Keyword(s):
Keyword(s):
2007 ◽
Vol 177
(4S)
◽
pp. 7-7
◽
Keyword(s):
Keyword(s):
Keyword(s):
2004 ◽
Vol 171
(4S)
◽
pp. 79-79
◽
2004 ◽
Vol 171
(4S)
◽
pp. 42-42
◽